ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

Stop Cancer Still Working To Raise Funds

March 22, 1991

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010